Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone in adults with autism
NCT01881737Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jul 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pregnenolone in Autism Spectrum Disorder (ASD), sponsored by Stanford University. Primary endpoint: Number of Participants With Adverse Events According to Dosage Record and Treatment Emergent Symptom at 16 weeks. Started Jul 2011; status: completed.
02
Drugs
pregnenolone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01881737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01881737.